A randomized, controlled trial of liraglutide for adolescents with obesity (SCALE TEENS)
This allows the intact tripeptide to safely reach the lower intestinal tract, where it is gradually released and absorbed over an extended period
Pharmacokinetics Absorption And Bioavailability The pharmacokinetic profiles for single 0.4, 0.6, and 0.9 U/kg doses of TOUJEO in 24 patients with type 1 diabetes mellitus was evaluated in a euglycemic clamp study
Phase Tirz escalation 1 Weeks 5-8 Tirzepatide 5.0 mg/week Cagrilintide Not started Notes Continue tirzepatide alone
The FDA has not identified signals suggesting increased overall cancer risk that would warrant additional warnings beyond the thyroid-specific precaution
Summarize key points in the medical record, including what evidence was reviewed, how uncertainties were described, and what followup plan was agreed upon